Information Library
Presentations - Targeted communications
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Medicare Part D’s Effect On Prescribing Volume
June 25, 2009
Poster presented during the ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) titled “Medicare Part D’s Effect On Prescribing Volume: Average Monthly Utilization of Selected High Use Drugs In The Six Protected Classes, By Different Specialties.” -
Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.
June 24, 2009
Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.” -
Innovex Medical Communications Experience
June 5, 2009
Innovex Medical Communications (IMC) has over 20 years of experience delivering global medical communication programmes for the top 20 global Pharma companies. -
Organizing Events, Advisory Boards and Meetings
June 5, 2009
In the past 5 years, IMC has delivered over 250 meetings to 13,500 delegates. -
IMC Multi-Country Expertise
June 5, 2009
Our educational materials have been used in over 30 countries and translated into 48 languages. -
Contact Details IMC
June 5, 2009
Names & contact details of IMC contact persons.
Page 1 of 1 (6 items)